News Releases

Einstein's M.D. Class of 2026 Celebrates at Annual White Coat Ceremony
Einstein-Created Drugs Show Promise Against an Incurable Eye Disease
Study Finds That an Autism Deficit May 'Disappear' in Adulthood

Facts & Stats

Published Papers
NIH Research Funding
Full-time Faculty
Global Initiatives
Clinical and Research Centers

Expert List for Media

Julio A. Aguirre-Ghiso

Julio A. Aguirre-Ghiso, Ph.D.

Area(s) of expertise: Cancer biologyCancer dormancy and the tumor microenvironmentCancer metastasis

Julio Aguirre-Ghiso, Ph.D., is an international leader in cancer cell dormancy and metastasis. He has helped lead a major shift in the cancer biology field by investigating how cancer cells hibernate, undetected, for long periods of time and what causes… Learn more

Einstein in the News

The New York Times
What School Anxiety Dreams Teach Us About Ourselves (subscription required)

Shelby Freedman Harris, Psy.D., comments on the role of stress in triggering nightmares and suggests having consistent sleep and wake times to help improve the quality and duration of sleep. Dr. Harris is clinical associate professor in The Saul R. Korey Department of Neurology and of psychiatry and behavioral sciences at Einstein.

More coverage on Dr. Harris

The New York Times
Pain in Children is Often Ignored. For Children of Color, It's Even Worse (subscription required)

Cristina Gonzalez, M.D., M.Ed., an expert in implicit bias recognition and management, recalls the case of a young Hispanic patient whose caregivers initially doubted his pain level, which could have delayed his treatment and led to life-threatening damage. Dr. Gonzalez is professor of medicine at Einstein and a hospitalist at Montefiore.

As Billionaires Race to Fund Anti-Aging Projects, a Much-Discussed Trial Goes Overlooked

Nir Barzilai, M.D., discusses the challenges of funding a clinical trial to test the effects of the diabetes drug metformin on delaying age-associated diseases like cancer, diabetes, and heart disease. Dr. Barzilai is professor of medicine and of genetics, the Ingeborg and Ira Leon Rennert Chair in Aging Research and director of the Institute for Aging Research at Einstein, and an endocrinologist at Montefiore.

More coverage on Dr. Barzilai


When a Drug Becomes a Child’s Last Hope

Einstein scientist Vern Schramm, Ph.D., never imagined that his basic research into enzymes would intersect with a 2-year-old girl dying from an incurable form of blood cancer. He and that girl (Katie Lambertson, now a teenager) and her parents share their stories.

Watch more videos